This strategic integration expands Herspiegel's proven market access capabilities and enhances Herspiegel's global footprint. The integrated global access services will support patient access to life-saving and life-altering therapies through industry-leading expertise across the access value chain including strategy, health economic modeling, outcomes research, Health Technology Assessments (HTA), value communications, pricing and reimbursement, and Real-World Evidence (RWE).
BDO has provided financial and commercial vendor due diligence to FIECON ahead of the investment, demonstrating their strong sector expertise and multi service approach.
"It was a pleasure working with the whole team at BDO. They were rigorous in their approach, pragmatic with their insights, and collaborative throughout the process. Their expertise in the life sciences industry, and with founder-led businesses helped us reach a great outcome on the deal."
Kuntal Fisher, Founder, Fiecon Group Limited
"We are really proud to have supported FIECON in securing their investment from Herspiegel. FIECON is a fast growing, market leader within health economics and market access consultancy and we look forward to seeing where the combined business goes next. This was a great opportunity to demonstrate BDOs Life Science sector expertise, and ability to deliver a joined up financial and commercial diligence offering."
Graeme Hurst, Partner, BDO LLP
The BDO project team included:
Graeme Hurst, Lewis Winston (Financial due diligence)
Gurpal Ahluwalia, Dodi Behiri and David Wentholt (CDD)